Biologically based treatment approaches to the patient with resistant perinatal depression

Archives of Women's Mental Health

Volumn 16, Issue 5, 2013, Pages 343-351

  Robakis, Thalia K ^a   Williams, Katherine Ellie ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antenatal depression; Antidepressants; Postpartum depression; Pregnancy; Treatment resistant depression

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; CARBAMAZEPINE; ESTRADIOL; ESTROGEN; FLUOXETINE; GABAPENTIN; HALOPERIDOL; LEVOMEPROMAZINE; LIOTHYRONINE; LITHIUM; NEFAZODONE; NEUROLEPTIC AGENT; NORTRIPTYLINE; OLANZAPINE; PAROXETINE; PHENYTOIN; PLACEBO; PROGESTERONE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TOPIRAMATE; VALPROIC ACID; VENLAFAXINE; ZUCLOPENTHIXOL;

ANXIETY; COGNITIVE DEFECT; COGNITIVE THERAPY; CONGENITAL HEART MALFORMATION; DEPRESSION; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG USE; ELECTROCONVULSIVE THERAPY; EPILEPTIC STATE; FATIGUE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSOMNIA; MATERNAL DISEASE; MEDICAL DECISION MAKING; MEDICAL RESEARCH; PERINATAL DEPRESSION; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PSYCHOTHERAPY; PUERPERAL DEPRESSION; REVIEW; SIDE EFFECT; SOLUTIO PLACENTAE; SYSTEMATIC REVIEW; TERATOGENICITY; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESISTANT DEPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; VAGINA BLEEDING; VAGUS NERVE STIMULATION; WEIGHT GAIN;

DEPRESSION, POSTPARTUM; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; PERINATAL CARE; POSTPARTUM PERIOD; PREGNANCY; PSYCHOTROPIC DRUGS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 84885020300     PISSN: 14341816     EISSN: 14351102     Source Type: Journal    
DOI: 10.1007/s00737-013-0366-7     Document Type: Review

References (85)

1. Ahokas A, Kaukoranta J, Wahlbeck K, Aito M (2001) Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study. J Clin Psychiatry 62(5):332-336
2. Anderson EL, Reti IM (2009) ECT in pregnancy: a review of the literature from 1941 to 2007. Psychosomatic Medicine 71(2):235-242
3. Appleby L, Warner R, Whitton A, Faragher B (1997) A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. BMJ 314(7085):932-936
4. Balki M, Castro C, Ananthanarayan C (2006) Status epilepticus after electroconvulsive therapy in a pregnant patient. Int J Obstet Anesth 15(4):325-328
5. Berlim MT, Turecki G (2007a) Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Can J Psychiatr Revue Canadienne De Psychiatrie 52(1):46-54
6. Berlim MT, Turecki G (2007b) What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. Eur Neuropsychopharmacol 17(11):696-707
7. Bloch M, Daly RC, Rubinow DR (2003) Endocrine factors in the etiology of postpartum depression. Comprehensive Psychiatry 44(3):234-246
8. Bobo WV, Shelton RC (2009) Fluoxetine and olanzapine combination therapy in treatment-resistant major depression: review of efficacy and safety data. Expert Opin Pharmacother 10(13):2145-2159
9. Brand SR, Brennan PA (2009) Impact of antenatal and postpartum maternal mental illness: how are the children? Clin Obstet Gynecol 52(3):441-455
10. Brandon AR, Freeman MP (2011) When she says "no" to medication: psychotherapy for antepartum depression. Current Psychiatry Reports 13(6):459-466
11. Byatt N, Deligiannidis KM, Freeman MP (2013) Antidepressant use in pregnancy: a critical review focused on risks and controversies. Acta Psychiatr Scand 127(2):94-114
12. Chabrol H, Teissedre F, Saint-Jean M, Teisseyre N, Roge B, Mullet E (2002) Prevention and treatment of post-partum depression: a controlled randomized study on women at risk. Psychol Med 32(6):1039-1047
13. Chatzicharalampous C, Rizos D, Pliatsika P, Leonardou A, Hasiakos D, Zervas I et al (2011) Reproductive hormones and postpartum mood disturbances in Greek women. Gynecol Endocrinol 27(8):543-550
14. Cohen LS, Viguera AC, Bouffard SM, Nonacs RM, Morabito C, Collins MH et al (2001) Venlafaxine in the treatment of postpartum depression. J Clin Psychiatr 62(8):592-596
15. Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC et al (2006) Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295(5):499-507
16. Cooper PJ, Murray L, Wilson A, Romaniuk H (2003) Controlled trial of the short- and long-term effect of psychological treatment of post-partum depression. I. Impact on maternal mood. Br J Psychiatr 182:412-419
17. Coppola D, Russo LJ, Kwarta RF Jr, Varughese R, Schmider J (2007) Evaluating the postmarketing experience of risperidone use during pregnancy: pregnancy and neonatal outcomes. Drug Saf 30(3):247-264
18. Coverdale JH, McCullough LB, Chervenak FA (2008) The ethics of randomized placebo-controlled trials of antidepressants with pregnant women: a systematic review. Obstet Gynecol 112(6):1361-1368
19. Cuijpers P, Brannmark JG, van Straten A (2008) Psychological treatment of postpartum depression: a meta-analysis. J Clin Psychol 64(1):103-118
20. Danielsson I, Lister L (2009) A pilot study of the teratogenicity of vagus nerve stimulation in a rabbit model. Brain Stimulation 2(1):41-49
21. Davalos DB, Yadon CA, Tregellas HC (2012) Untreated prenatal maternal depression and the potential risks to offspring: a review. Archives of Women's Mental Health 15(1):1-14
22. Deligiannidis KM (2010) Therapeutic drug monitoring in pregnant and postpartum women: recommendations for SSRIs, lamotrigine, and lithium. J Clin Psychiatr 71(5):649-650
23. Dennis CL, Hodnett E (2007) Psychosocial and psychological interventions for treating postpartum depression. Cochrane Database of Systematic Reviews (4):CD006116
24. Dennis CL, Ross LE, Grigoriadis S (2007) Psychosocial and psychological interventions for treating antenatal depression. Cochrane Database of Systematic Reviews (3):CD006309
25. Dietz PM, Williams SB, Callaghan WM, Bachman DJ, Whitlock EP, Hornbrook MC (2007) Clinically identified maternal depression before, during, and after pregnancies ending in live births. Am J Psychiatry 164(10):1515-1520
26. Dimidjian S, Goodman S (2009) Nonpharmacologic intervention and prevention strategies for depression during pregnancy and the postpartum. Clin Obstet Gynecol 52(3):498-515
27. Echevarria Moreno M, Martin Munoz J, Sanchez Valderrabanos J, Vazquez Gutierrez T (1998) Electroconvulsive therapy in the first trimester of pregnancy. The Journal of ECT 14(4):251-254
28. Epstein RA, Bobo WV, Shelton RC, Arbogast PG, Morrow JA, Wang W et al (2012) Increasing use of atypical antipsychotics and anticonvulsants during pregnancy. Pharmacoepidemiol Drug Saf. doi: 10.1002/pds.3366
29. Fahy BG (2010) Intraoperative and perioperative complications with a vagus nerve stimulation device. J Clin Anesth 22(3):213-222
30. Field T (2011) Prenatal depression effects on early development: a review. Infant Behav Dev 34(1):1-14
31. Fink M (2011) Transcranial magnetic stimulation is not a replacement for electroconvulsive therapy in depressive mood disorders. The Journal of ECT 27(1):3-4
32. Forssman H (1955) Follow-up study of sixteen children whose mothers were given electric convulsive therapy during gestation. Acta Psychiatrica Et Neurologica Scandinavica 30(3):437-441
33. Gahr M, Blacha C, Connemann BJ, Freudenmann RW, Schonfeldt-Lecuona C (2011) Successful treatment of major depression with electroconvulsive therapy in a pregnant patient with previous non-response to prefrontal rTMS. Pharmacopsychiatry 45(2):79-80
34. Galbally M, Roberts M, Buist A (2010) Mood stabilizers in pregnancy: a systematic review. Aust New Zeal J Psychiatr 44(11):967-977
35. Garber J, Ciesla JA, McCauley E, Diamond G, Schloredt KA (2011) Remission of depression in parents: links to healthy functioning in their children. Child Development 82(1):226-243
36. Garcia KS, Flynn P, Pierce KJ, Caudle M (2010) Repetitive transcranial magnetic stimulation treats postpartum depression. Brain Stimulation 3(1):36-41
37. Gentile S (2010) Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophr Bull 36(3):518-544
38. George MS, Rush AJ, Marangell LB, Sackeim HA, Brannan SK, Davis SM et al (2005) A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 58(5):364-373
39. Gilot B, Gonzalez D, Bournazeau JA, Barriere A, Van Lieferinghen P (1999) Case report: electroconvulsive therapy during pregnancy (electroconvulsivotherapie au troisieme trimestre de grossesse: a propos d'un cas). L'Encephale 25(6):590-594
40. Gregoire AJ, Kumar R, Everitt B, Henderson AF, Studd JW (1996) Transdermal oestrogen for treatment of severe postnatal depression. Lancet 347(9006):930-933
41. Hendrick V, Altshuler L, Strouse T, Grosser S (2000) Postpartum and nonpostpartum depression: differences in presentation and response to pharmacologic treatment. Depress Anxiety 11(2):66-72
42. Honey KL, Bennett P, Morgan M (2002) A brief psycho-educational group intervention for postnatal depression. Br J Clin Psychol 41(Pt 4):405-409
43. Hostetter A, Stowe ZN, Strader JR Jr, McLaughlin E, Llewellyn A (2000) Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications. Depression and Anxiety 11(2):51-57
44. Houser MV, Hennessy MD, Howard BC (2010) Vagal nerve stimulator use during pregnancy for treatment of refractory seizure disorder. Obstet Gynecol 115(2 Pt 2):417-419
45. Husain MM, Stegman D, Trevino K (2005) Pregnancy and delivery while receiving vagus nerve stimulation for the treatment of major depression: a case report. Annals of General Psychiatry 4:16
46. Impastato DJ, Gabriel AR, Lardaro HH (1964) Electric and insulin shock therapy during pregnancy. Diseases of the Nervous System 25:542-546
47. Johnson KC, Laprairie JL, Brennan PA, Stowe ZN, Newport DJ (2012) Prenatal antipsychotic exposure and neuromotor performance during infancy. Arch Gen Psychiatry 69(8):787-94
48. Kim DR, Epperson N, Pare E, Gonzalez JM, Parry S, Thase ME et al (2011) An open label pilot study of transcranial magnetic stimulation for pregnant women with major depressive disorder. Journal of Women's Health 20(2):255-261
49. Klier CM, Mossaheb N, Saria A, Schloegelhofer M, Zernig G (2007a) Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum. J Clin Psychopharmacol 27(6):720-722
50. Klier CM, Muzik M, Dervic K, Mossaheb N, Benesch T, Ulm B et al (2007b) The role of estrogen and progesterone in depression after birth. J Psychiatr Res 41(3-4):273-279
51. Klirova M, Novak T, Kopecek M, Mohr P, Strunzova V (2008) Repetitive transcranial magnetic stimulation (rTMS) in major depressive episode during pregnancy. Neuro Endocrinology Letters 29(1):69-70
52. Marcus SM (2009) Depression during pregnancy: rates, risks and consequences - Motherisk update 2008. Can J Clin Pharmacol 16(1):e15-22
53. McKenna K, Koren G, Tetelbaum M, Wilton L, Shakir S, Diav-Citrin O et al (2005) Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study. The J of Clin Psychiatry 66(4):444-9, quiz 546
54. Milgrom J, Negri LM, Gemmill AW, McNeil M, Martin PR (2005) A randomized controlled trial of psychological interventions for postnatal depression. Br J Clin Psychol 44(Pt 4):529-542
55. Miller LJ (1994) Use of electroconvulsive therapy during pregnancy. Hospital & Community Psychiatry 45(5):444-450
56. Misri S, Reebye P, Corral M, Milis L (2004) The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J Clin Psychiatry 65(9):1236-1241
57. Moses-Kolko EL, Berga SL, Kalro B, Sit DK, Wisner KL (2009) Transdermal estradiol for postpartum depression: a promising treatment option. Clin Obstet Gynecol 52(3):516-529
58. Mulcahy R, Reay RE, Wilkinson RB, Owen C (2010) A randomised control trial for the effectiveness of group interpersonal psychotherapy for postnatal depression. Archives of Women's Mental Health 13(2):125-139
59. Nahas Z, Marangell LB, Husain MM, Rush AJ, Sackeim HA, Lisanby SH et al (2005) Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 66(9):1097-1104
60. Nonacs RM, Soares CN, Viguera AC, Pearson K, Poitras JR, Cohen LS (2005) Bupropion SR for the treatment of postpartum depression: a pilot study. Int J Neuropsychopharmacol 8(3):445-449
61. Oates M (2003) Perinatal psychiatric disorders: a leading cause of maternal morbidity and mortality. British Medical Bulletin 67:219-229
62. Oberlander TF, Warburton W, Misri S, Riggs W, Aghajanian J, Hertzman C (2008) Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data. Birth Defects Res B Dev Reprod Toxicol 83(1):68-76
63. Paulson JF, Bazemore SD (2010) Prenatal and postpartum depression in fathers and its association with maternal depression: a meta-analysis. JAMA 303(19):1961-1969
64. Pinette MG, Santarpio C, Wax JR, Blackstone J (2007) Electroconvulsive therapy in pregnancy. Obstet Gynecol 110(2 Pt 2):465-466
65. Rasmussen KG (2011) Some considerations in choosing electroconvulsive therapy versus transcranial magnetic stimulation for depression. J ECT 27(1):51-54
66. Reis M, Kallen B (2008) Maternal use of antipsychotics in early pregnancy and delivery outcome. J Clin Psychopharmacol 28(3):279-288
67. Rush AJ, George MS, Sackeim HA, Marangell LB, Husain MM, Giller C et al (2000) Vagus nerve stimulation (VNS) for treatment-resistant depressions: a multicenter study. Biol Psychiatry 47(4):276-286
68. Sackeim HA, Rush AJ, George MS, Marangell LB, Husain MM, Nahas Z et al (2001) Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome. Neuropsychopharmacology 25(5):713-728
69. Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR (1998) Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Engl J Med 338(4):209-216
70. Sit DK, Perel JM, Helsel JC, Wisner KL (2008) Changes in antidepressant metabolism and dosing across pregnancy and early postpartum. J Clin Psychiatry 69(4):652-658
71. Smith S (1956) The use of electroplexy (E.C.T.) in psychiatric syndromes complicating pregnancy. J Ment Sci 102(429):796-800
72. Sockol LE, Epperson CN, Barber JP (2011) A meta-analysis of treatments for perinatal depression. Clin Psychol Rev 31(5):839-849
73. Stowe ZN, Owens MJ, Landry JC, Kilts CD, Ely T, Llewellyn A et al (1997) Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psychiatry 154(9):1255-1260
74. Sugawara M, Toda MA, Shima S, Mukai T, Sakakura K, Kitamura T (1997) Premenstrual mood changes and maternal mental health in pregnancy and the postpartum period. J Clin Psychol 53(3):225-232
75. Suri R, Burt VK, Altshuler LL, Zuckerbrow-Miller J, Fairbanks L (2001) Fluvoxamine for postpartum depression. Am J Psychiatry 158(10):1739-1740
76. Suri R, Burt VK, Altshuler LL (2005) Nefazodone for the treatment of postpartum depression. Archives of Women's Mental Health 8(1):55-56
77. US Food and Drug Administration (2008) VNS therapy system, premarket approval: supplement. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/ pma-template.cfm?id=p970003s050. Accessed 28 June 2013
78. Warden D, Rush AJ, Trivedi MH, Fava M, Wisniewski SR (2007) The STAR D project results: a comprehensive review of findings. Current Psychiatry Reports 9(6):449-459
79. Wickramaratne P, Gameroff MJ, Pilowsky DJ, Hughes CW, Garber J, Malloy E et al (2011) Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR D-child study. Am J Psychiatry 168(6):593-602
80. Wiklund I, Mohlkert P, Edman G (2010) Evaluation of a brief cognitive intervention in patients with signs of postnatal depression: a randomized controlled trial. Acta Obstetricia Et Gynecologica Scandinavica 89(8):1100-1104
81. Wisner KL, Hanusa BH, Perel JM, Peindl KS, Piontek CM, Sit DK et al (2006) Postpartum depression: a randomized trial of sertraline versus nortriptyline. J Clin Psychopharmacol 26(4):353-360
82. Yonkers KA, Lin H, Howell HB, Heath AC, Cohen LS (2008) Pharmacologic treatment of postpartum women with new-onset major depressive disorder: a randomized controlled trial with paroxetine. J Clin Psychiatry 69(4):659-665
83. Yonkers KA, Gotman N, Smith MV, Forray A, Belanger K, Brunetto WL et al (2011) Does antidepressant use attenuate the risk of a major depressive episode in pregnancy? Epidemiology 22(6):848-854
84. Zhang D, Hu Z (2009) RTMS may be a good choice for pregnant women with depression. Archives of Women's Mental Health 12(3):189-190
85. Zhang X, Liu K, Sun J, Zheng Z (2010) Safety and feasibility of repetitive transcranial magnetic stimulation (rTMS) as a treatment for major depression during pregnancy. Archives of Women's Mental Health 13(4):369-370